Related references
Note: Only part of the references are listed.Combined use of multiparametric flow cytometry and cytomorphology to enhance detection of neuroblastoma metastatic cells in bone marrow
Christine Manenq et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells
Hong-Wei Wu et al.
CLINICAL CANCER RESEARCH (2019)
Interference of bone marrow CD56+ mesenchymal stromal cells in minimal residual disease investigation of neuroblastoma and other CD45-/CD56+ pediatric malignancies using flow cytometry
Ioannis Theodorakos et al.
PEDIATRIC BLOOD & CANCER (2019)
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies
Alessandra Marrella et al.
FRONTIERS IN IMMUNOLOGY (2019)
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Mariya Lazarova et al.
FRONTIERS IN IMMUNOLOGY (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma
Alexander Popov et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Blocking don't eat me signal of CD47-SIRPα in hematological malignancies, an in-depth review
Atlantis Russ et al.
BLOOD REVIEWS (2018)
Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
Tao Jiang et al.
BMC CANCER (2018)
Spontaneous regression of neuroblastoma
Garrett M. Brodeur
CELL AND TISSUE RESEARCH (2018)
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
Andre Veillette et al.
TRENDS IN IMMUNOLOGY (2018)
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma
Noemie Braekeveldt et al.
CANCER RESEARCH (2018)
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2018)
Recommendations for the Standardization of Bone Marrow Disease Assessment and Reporting in Children With Neuroblastoma on Behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group
Susan A. Burchill et al.
CANCER (2017)
Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence
Roswitha Schumacher-Kuckelkorn et al.
PEDIATRIC BLOOD & CANCER (2017)
New B7 Family Checkpoints in Human Cancers
Ling Ni et al.
MOLECULAR CANCER THERAPEUTICS (2017)
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27
Alessandra Dondero et al.
ONCOTARGET (2017)
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
Ombretta Melaiu et al.
CLINICAL CANCER RESEARCH (2017)
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
Steven Seaman et al.
CANCER CELL (2017)
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
Alessandra Dondero et al.
ONCOIMMUNOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm et al.
NATURE GENETICS (2015)
Endoglin (CD 105) as a Potential Prognostic Factor in Neuroblastoma
Stanko Cavar et al.
PEDIATRIC BLOOD & CANCER (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
Michaela Semeraro et al.
Science Translational Medicine (2015)
Human NK cells and NK receptors
Francesca Bellora et al.
IMMUNOLOGY LETTERS (2014)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Deryk Loo et al.
CLINICAL CANCER RESEARCH (2012)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule
A. Gregorio et al.
HISTOPATHOLOGY (2008)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow
K Swerts et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Detecting minimal residual disease in neuroblastoma patients - the present state of the art
K Beiske et al.
CANCER LETTERS (2005)
Mechanisms of immune evasion of human neuroblastoma
L Raffaghello et al.
CANCER LETTERS (2005)
Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains
P Steinberger et al.
JOURNAL OF IMMUNOLOGY (2004)
Identification of 41g-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction
R Castriconi et al.
CANCER RESEARCH (2004)
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
KE Sloan et al.
BMC CANCER (2004)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Share Paper
